Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporin and Steroid for Newly Diagnosed ITP
NCT05459649Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2022
- Primary completion
- Jul 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
cyclosporine
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT05459649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05459649.